JP2015505540A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015505540A5 JP2015505540A5 JP2014553530A JP2014553530A JP2015505540A5 JP 2015505540 A5 JP2015505540 A5 JP 2015505540A5 JP 2014553530 A JP2014553530 A JP 2014553530A JP 2014553530 A JP2014553530 A JP 2014553530A JP 2015505540 A5 JP2015505540 A5 JP 2015505540A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- infection
- subject
- sandalwood oil
- effective amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261589601P | 2012-01-23 | 2012-01-23 | |
| US61/589,601 | 2012-01-23 | ||
| PCT/US2013/022743 WO2013112582A1 (en) | 2012-01-23 | 2013-01-23 | Sandalwood oil and its uses related to clostridium infections |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015505540A JP2015505540A (ja) | 2015-02-23 |
| JP2015505540A5 true JP2015505540A5 (cg-RX-API-DMAC7.html) | 2015-12-24 |
| JP6134739B2 JP6134739B2 (ja) | 2017-05-24 |
Family
ID=48873861
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014553530A Expired - Fee Related JP6134739B2 (ja) | 2012-01-23 | 2013-01-23 | ビャクダン油およびクロストリジウム感染症に関連するその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US9579354B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2806882B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6134739B2 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2013212264B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2862483A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013112582A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140154342A1 (en) * | 2011-07-28 | 2014-06-05 | Santalis Pharmaceuticals Inc. | Sandalwood oil and its uses related to skin disorders |
| WO2014160279A1 (en) | 2013-03-13 | 2014-10-02 | Viroxis Corporation | Stabilized cream formulations comprising sandalwood oil |
| JP2018529752A (ja) | 2015-10-07 | 2018-10-11 | サンタリス ファーマシューティカルズ インコーポレイテッド | サンダルウッド油及び口腔粘膜炎に関連するその用途 |
| WO2018165108A1 (en) | 2017-03-08 | 2018-09-13 | Hope Medical Enterprises, Inc. Dba Hope Pharmaceuticals | Intradialytic use of sodium thiosulfate |
| KR102647803B1 (ko) | 2017-03-08 | 2024-03-15 | 호프 메디칼 엔터프라이즈스, 인크, 디비에이, 호프파마수으티칼즈 | 아질산나트륨의 투석중 용도 |
| CA3109900A1 (en) * | 2018-08-17 | 2020-02-20 | Universidad Andres Bello | Method and pharmacological composition for the prevention of recurrent infections caused by clostridium difficile |
| CN111544353A (zh) * | 2020-05-21 | 2020-08-18 | 天津芸熙生物技术有限公司 | 一种抑菌口腔喷雾剂及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996007430A1 (en) | 1994-09-06 | 1996-03-14 | Galagen, Inc. | Therapeutic treatment of clostridium difficile associated diseases |
| GB0414886D0 (en) | 2004-07-02 | 2004-08-04 | Neutec Pharma Plc | Treatment of bacterial infections |
| JP2006124296A (ja) * | 2004-10-27 | 2006-05-18 | Tomihiko Higuchi | ヘリコバクター・ピロリ菌感染症治療のための医薬組成物 |
| US7858126B2 (en) * | 2006-08-31 | 2010-12-28 | Trinity Laboratories Inc. | Derivatives of sandalwood oil and santalols for treating cold sores and herpes |
| WO2009014781A2 (en) * | 2007-05-02 | 2009-01-29 | Nucryst Pharmaceuticals Corp. | Metal-containing materials for treatment of bacterial conditions |
| KR101842289B1 (ko) * | 2010-03-01 | 2018-03-26 | 산탈리스 파마슈티컬스, 인크. | 백단유 및 이의 용도 |
| AU2011239470B2 (en) | 2010-04-15 | 2015-09-10 | Progenics Pharmaceuticals, Inc. | Antibodies for the treatment of Clostridium difficile-associated infection and disease |
| WO2011146624A2 (en) * | 2010-05-18 | 2011-11-24 | Optimer Pharmaceuticals, Inc. | Methods of treating recurring bacterial infection |
| US20130224164A1 (en) * | 2010-09-10 | 2013-08-29 | Viropharma Incorporated | Environmental Clostridial Bacteriotherapy and Related Formulations and Methods of Manufacture and Use |
-
2013
- 2013-01-23 CA CA2862483A patent/CA2862483A1/en not_active Abandoned
- 2013-01-23 WO PCT/US2013/022743 patent/WO2013112582A1/en not_active Ceased
- 2013-01-23 AU AU2013212264A patent/AU2013212264B2/en not_active Ceased
- 2013-01-23 EP EP13741240.9A patent/EP2806882B1/en not_active Not-in-force
- 2013-01-23 US US14/373,810 patent/US9579354B2/en not_active Expired - Fee Related
- 2013-01-23 JP JP2014553530A patent/JP6134739B2/ja not_active Expired - Fee Related
-
2017
- 2017-01-13 US US15/405,921 patent/US10322154B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Giannelli et al. | The rationale for targeting TGF‐β in chronic liver diseases | |
| MX2020002118A (es) | Oligómeros antisentido para tratamiento de afecciones y enfermedades. | |
| HRP20200925T1 (hr) | Pripravak za liječenje dijabetesa koji uključuje analog oksintomodulina | |
| NZ731657A (en) | Composition for treating hyperlipidemia comprising oxyntomodulin derivative | |
| JP2018503668A5 (cg-RX-API-DMAC7.html) | ||
| DOP2017000177A (es) | Nuevos anticuerpos anti-cd38 para el tratamiento del cáncer | |
| MX339469B (es) | Agentes inductores de apotosis para el tratamiento de cancer y enfermedades inmunes y autoinmunes. | |
| MY157564A (en) | Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract | |
| JP2013067645A5 (cg-RX-API-DMAC7.html) | ||
| CN114341148B (zh) | 抗衰老和抗炎前药及其使用方法 | |
| BR112012029975A2 (pt) | peptídeo como medicamento, em particular para o tratamento do câncer. | |
| JP2016502515A5 (cg-RX-API-DMAC7.html) | ||
| Garcia-Olmo et al. | Cumulative evidence that mesenchymal stem cells promote healing of perianal fistulas of patients with Crohn's Disease–Going From Bench to Bedside | |
| CN110114083A (zh) | 一种预防和治疗脂肪肝的方法 | |
| JOP20240254A1 (ar) | عمليات ومركب وسيط لتحضير واسع النطاق لـ 2، 4، 6-تراي فلورو-n--بنزاميد هيمي سكسينات، وتحضير 2، 4، 6-تراي فلورو-n--بنزاميد أسيتات | |
| JP2017503014A5 (cg-RX-API-DMAC7.html) | ||
| BR112017018328A2 (pt) | anticorpo de ligação ao tfpi, método para produzir e composição compreendendo o mesmo | |
| BR112023016445A2 (pt) | Anticorpos anti-cd30l e seus usos | |
| Durbin | Dengue vascular leak syndrome: insights into potentially new treatment modalities | |
| JP2018511303A5 (cg-RX-API-DMAC7.html) | ||
| TNSN08537A1 (fr) | Precurseurs de medicaments du type peneme | |
| RU2015134356A (ru) | Пептид | |
| PE20130308A1 (es) | Metodos para tratar infecciones bacterianas recurrentes | |
| JP2019510519A5 (cg-RX-API-DMAC7.html) | ||
| Watson et al. | Treatment of inflammatory bowel disease with genetically engineered bacteria |